-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HIV-IN-4
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/2408729-03-1.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 2408729-03-1 |
| Description | HIV-IN-4 (Compound 12) is a potent inhibitor of HIV. HIV-IN-4 shows promising anti-HIV activities. |
Product Information
| Synonyms | HIV-IN-4|CHEMBL4796878|HY-146363|CS-0498477|isobutyl (2S)-2-methyl-3-oxo-2,4-dihydroquinoxaline-1-carboxylate |
| Molecular Weight | 262.3 |
| Molecular Formula | C14H18N2O3 |
| Canonical SMILES | CC1C(=O)NC2=CC=CC=C2N1C(=O)OCC(C)C |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 357 |
| Exact Mass | 262.13174244 |
| Target | HIV |
| XLogP3-AA | 2.4 |